Microvascular Tissues
MicroVascular Tissues, Inc. is a privately held company founded in 2014 as a management-led spin-out from Tornier, Inc., now part of Stryker Corp. The company specializes in microvascular tissue science, developing products like mVASC, a human cadaver-derived extracellular matrix disk intended for repair, reconstruction, and replacement of damaged ECM in skin defects. Located in San Diego, CA, MVT focuses on innovating in the field of microvascular tissues to address unmet clinical needs.
Industries
Nr. of Employees
small (1-50)
Microvascular Tissues
San Diego, California, United States, North America
Products
Human cadaver-derived extracellular matrix disc for dermal and hypodermal repair
A 19.5 mm diameter disc derived from human cadaver hypodermal extracellular matrix, embedded in a cryopreservative and crystalloid, aseptically processed, lyophilized, and terminally sterilized (SAL 10^-6). Intended for repair, reconstruction, replacement, or supplementation of damaged ECM in skin defects that extend through the dermis into and/or through the hypodermis.
Human cadaver-derived extracellular matrix disc for dermal and hypodermal repair
A 19.5 mm diameter disc derived from human cadaver hypodermal extracellular matrix, embedded in a cryopreservative and crystalloid, aseptically processed, lyophilized, and terminally sterilized (SAL 10^-6). Intended for repair, reconstruction, replacement, or supplementation of damaged ECM in skin defects that extend through the dermis into and/or through the hypodermis.
Services
Collaborative development partnerships in microvascular tissue science
Engagement with industry and medical community partners to collaborate on development and innovation of microvascular tissue products.
Collaborative development partnerships in microvascular tissue science
Engagement with industry and medical community partners to collaborate on development and innovation of microvascular tissue products.
Expertise Areas
- Tissue-derived biomaterials
- Dermal and hypodermal soft tissue repair
- Human tissue processing and sterilization
- Medical implant product commercialization
Key Technologies
- Decellularized extracellular matrix (ECM)
- Cryopreservation of tissue grafts
- Lyophilization (freeze-drying)
- Terminal sterilization (SAL 10^-6)